Skip to main content

Research and statistics

Skip to results
404 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Reports relating to the national point prevalence survey (PPS) on healthcare-associated infections (HCAIs), antimicrobial use (AMU) and antimicrobial stewardship (AMS) in England, 2023.

  • Cumulative vaccine uptake data for the childhood seasonal influenza programme in England, 2024 to 2025 data.

  • Voluntary surveillance of paediatric bacteraemia in England.

  • Laboratory-confirmed cases of reported hepatitis C.

  • Latest UKHSA hepatitis B virus report and supporting document for England.

  • Annual reports from the national school leaver booster (tetanus, diphtheria and polio, Td/IPV) vaccination programme for adolescents.

  • Public health analysis of progress towards meeting the aims of England’s HIV Action Plan 2022 to 2025.

  • Annual survey results to monitor HIV testing activity in community-based testing services in England and evaluates the implementation of current guidelines.

  • Outlines the quality and methodology information (QMI) relevant to the healthcare-associated infections (HCAI) accredited official statistics releases.

  • Laboratory-confirmed cases of reported hepatitis C.

  • Laboratory-confirmed cases of reported hepatitis C.

  • Analysis and learning from radiotherapy and near miss data reported voluntarily by UK radiotherapy providers and the relevant reporting authorities.

  • Evaluation of the Shingrix® herpes zoster (shingles) vaccination programme in England: academic year 2023 to 2024.

  • The latest quarterly reports of provisional data for tuberculosis (TB) notifications in England.

  • Statistical releases in response to new cases of avian influenza in the United Kingdom.

  • Vaccine coverage data estimates and commentary relating to the national Meningococcal ACWY (MenACWY) immunisation programme.

  • HPV vaccine coverage data for vaccinations in England, broken down by local authority, NHS commissioning region, integrated care board (ICB), sub-integrated care board (sub-ICB) and UKHSA region.

  • This rapid review identified and summarised evidence published before 15 August 2022 relating to adherence and barriers to following isolation guidance for mpox (clade II).

  • This rapid evidence summary identified and summarised evidence relating to the incubation and infectious periods of mpox infection.

  • This rapid evidence summary identified and summarised evidence relating to routes of transmission in mpox (clade Ia, Ib, IIb).